Quipt Home Medical stock hits 52-week low at $2.23

Published 01/04/2025, 19:36
Quipt Home Medical stock hits 52-week low at $2.23

In a challenging market environment, Quipt Home Medical (TASE:BLWV) Corp. (QIPT) stock has touched a 52-week low, reaching $2.23. With a market capitalization of $97.3 million and robust gross margins of 71.89%, the company continues to generate substantial revenue of $244.72 million. InvestingPro analysis reveals several promising indicators for the company’s future performance. This downturn reflects a significant retreat from previous valuations, marking a stark contrast to the company’s performance over the past year. Investors have witnessed a substantial 1-year change, with Quipt Home Medical’s stock value declining by 46.32%. While current market pressures persist, analyst targets ranging from $4.00 to $8.25 suggest potential upside. InvestingPro subscribers can access additional insights, including 7 key tips and a comprehensive Pro Research Report, helping investors make more informed decisions in these volatile market conditions.

In other recent news, Quipt Home Medical Corp reported its Q1 2025 earnings, showing a mixed financial performance. The company posted an earnings per share (EPS) of -$0.03, which surpassed the forecasted -$0.08. However, revenue slightly missed expectations, coming in at $61.4 million against a forecast of $61.7 million. Quipt Home Medical experienced a net loss of $1.1 million for the quarter, but the EPS beat suggests some operational efficiencies. The company aims for 8-10% organic growth in 2025, according to its guidance.

Additionally, Quipt Home Medical held its annual general meeting, where shareholders re-elected all four nominated directors and approved the re-appointment of BDO USA, P.C. as auditors for the fiscal year ending September 30, 2025. The re-election of directors and auditor appointment were approved with a significant majority. The company continues to focus on expanding its respiratory care market presence and integrating technology into its operations. These developments reflect Quipt Home Medical’s ongoing efforts to strengthen its market position and operational efficiency.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.